Results 251 to 260 of about 545,708 (260)

Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence

Journal of Experimental Medicine, 2005
Julianne Stack, Nathan W Bartlett, Patrick C Reading   +2 more
exaly  

Toll-like receptor signalling

Nature Reviews Immunology, 2004
Shizuo Akira, Kiyoshi Takeda
exaly  

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells

Cell, 1988
Anjana Rao
exaly  

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

Nature, 1990
exaly  

Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain–containing proteins

Nature Medicine, 2008
Manisha Yadav, Hermann Wagner, Catharina Svanborg   +2 more
exaly  

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Lancet, The, 2017
Paul M Ridker, Athanasios J Manolis, Tom Thuren   +2 more
exaly  

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2016
J Mark Fitzgerald, Eugene R Bleecker, Parameswaran Nair   +2 more
exaly  

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

Nature, 1990
exaly  

Interleukin-7 receptor expression: intelligent design

Nature Reviews Immunology, 2007
exaly